Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation

Sheikh, I. N., Uwaezuoke, D., Okeleji, O., Quesada, A., Herzog, C. E., Ragoonanan, D., … Khazal, S. (2025, March 1). Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post-Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation. Pediatric Blood and Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/pbc.31489